GlassScriptPhysician profile
Nidia E Cardenas
NPI 1518566306
$4,060.85
in general payments reported to CMS, 2019-2025
22 companies · $2,044 in 2025
The $2,044 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $106 · 2023: $995 · 2024: $915 · 2025: $2,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,795 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,794.62 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,254.08 | 2023-2025 | Tremfya, Simponi Aria |
| Amgen INC. | $588.18 | 2022-2025 | Otezla, Tavneos, Krystexxa |
| Abbvie INC. | $579.30 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $299.72 | 2023-2025 | |
| Ucb, INC. | $264.04 | 2023-2025 | Bimzelx, Cimzia |
| Astrazeneca Pharmaceuticals LP | $241.66 | 2023-2024 | Saphnelo |
| Mallinckrodt Hospital Products INC. | $133.55 | 2023-2025 | Acthar |
| Genzyme Corporation | $119.71 | 2024 | |
| Radius Health, INC. | $94.30 | 2025 | Tymlos |
| Glaxosmithkline, LLC. | $81.80 | 2023 | Benlysta |
| Aurinia Pharma U.S., INC. | $55.36 | 2025 | Lupkynis |
| E.R. Squibb & Sons, L.L.C. | $51.93 | 2024-2025 | Orencia |
| Pfizer INC. | $51.78 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.71 | 2023 | Ofev |
| Organon LLC | $40.92 | 2025 | Nexplanon |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $28.74 | 2024 | Tremfya |
| Octapharma USA, INC. | $26.41 | 2023 | Octagam Immune Globulin (Human) |
| Lilly USA, LLC | $25.10 | 2023 | Taltz |
| Ani Pharmaceuticals, INC. | $23.86 | 2024 | Purified Cortrophin Gel |
| Inspire Medical Systems, INC. | $23.25 | 2023 | Inspire |
| Actelion Pharmaceuticals US, INC. | $16.88 | 2024 | |
| Sobi, INC | $13.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidia Cardenas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.